A comprehensive view of eli lilly & co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS"

US Patent Issued to Eli Lilly and Co. on Jan. 31 for "Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer" (Indiana Inventors)

Darryle D. Schoepp, Ph.D., former Merck and Eli Lilly executive, joins Scientific Advisory Board of Akelos Inc., a biotechnology company developing opioid alternatives; Dr. Schoepp recently retired from Merck after 30 years in the pharmaceutical industry

Eli Lilly and Company Seeks Patent for Novel RNA Therapeutics and Uses Thereof

Eli Lilly and Company Submits Patent Application for CD73 Inhibitors

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count